ImmunityBio, Inc. IBRX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s shares (diluted)?
- ImmunityBio, Inc. (IBRX) reported shares (diluted) of 1B in Q1 2026.
- How has ImmunityBio, Inc.'s shares (diluted) changed year-over-year?
- ImmunityBio, Inc.'s shares (diluted) increased by 20.4% year-over-year, from 853.2M to 1B.
- What is the long-term trend for ImmunityBio, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), ImmunityBio, Inc.'s shares (diluted) has grown at a 23.5% compound annual growth rate (CAGR), from 1.5B to 3.6B.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.